{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:06:00Z","timestamp":1790471160183,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.clnu.2012.11.014","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T13:05:52Z","timestamp":1354712752000},"page":"538-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks"],"prefix":"10.1016","volume":"32","author":[{"given":"E.D.","family":"Olthof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Rentenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.M.M.","family":"Rijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.A.","family":"Wanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2012.11.014_bib1","doi-asserted-by":"crossref","first-page":"d1447","DOI":"10.1136\/bmj.d1447","article-title":"Managing adult patients who need home parenteral nutrition","volume":"342","author":"Wanten","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2012.11.014_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clnu.2009.04.001","article-title":"ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients","volume":"28","author":"Staun","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clnu.2009.03.015","article-title":"ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications)","volume":"28","author":"Pittiruti","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0b013e31825bb0ae","article-title":"Significant reduction in central venous catheter related bloodstream infections in children on home parenteral nutrition after starting treatment with taurolidine line lock","author":"Chu","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1542\/peds.2011-1602","article-title":"Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis","volume":"129","author":"Oliveira","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2012.11.014_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.clnu.2005.02.001","article-title":"Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections","volume":"24","author":"Jurewitsch","year":"2005","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0148607198022004242","article-title":"Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections","volume":"22","author":"Jurewitsch","year":"1998","journal-title":"J\u00a0Parenter Eternal Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clnu.2009.12.005","article-title":"Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial","volume":"29","author":"Bisseling","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2004.06.006","article-title":"Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients","volume":"24","author":"Koldehoff","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clnu.2012.11.014_bib10","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1086\/375234","article-title":"Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution","volume":"36","author":"Allon","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clnu.2012.11.014_bib11","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/ndt\/gfh014","article-title":"Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution","volume":"19","author":"Betjes","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clnu.2012.11.014_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2334-8-102","article-title":"Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients","volume":"8","author":"Simon","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clnu.2012.11.014_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000046950","article-title":"Two years' experience with Dialock and CLS (a new antimicrobial lock solution)","volume":"19","author":"Sodemann","year":"2001","journal-title":"Blood Purif"},{"key":"10.1016\/j.clnu.2012.11.014_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/j.ajkd.2009.11.025","article-title":"A\u00a0randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis","volume":"55","author":"Solomon","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clnu.2012.11.014_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1755-6686.2008.00027.x","article-title":"A\u00a0new haemodialysis catheter-locking agent reduces infections in haemodialysis patients","volume":"34","author":"Taylor","year":"2008","journal-title":"J\u00a0Ren Care"},{"key":"10.1016\/j.clnu.2012.11.014_bib16","doi-asserted-by":"crossref","first-page":"e8927","DOI":"10.1371\/journal.pone.0008927","article-title":"Taurolidine antiadhesive properties on interaction with E.\u00a0coli; its transformation in biological environment and interaction with bacteria cell wall","volume":"5","author":"Caruso","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2012.11.014_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2672.1987.tb04926.x","article-title":"Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with taurolin, a novel antimicrobial agent","volume":"62","author":"Gorman","year":"1987","journal-title":"J\u00a0Appl Bacteriol"},{"key":"10.1016\/j.clnu.2012.11.014_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"EUCAST","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clnu.2012.11.014_bib19","article-title":"Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution","author":"EUCAST","year":"2003","journal-title":"Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clnu.2012.11.014_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0261-5614(87)90066-5","article-title":"The antimicrobial activity of taurolin - a possible additive for parenteral-nutrition solutions","volume":"6","author":"Blenkharn","year":"1987","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000178454","article-title":"In-vitro-Wirksamkeit von Taurolidin und 9 Antibiotika gegen klinische Isolate aus chirurgischem Einsendegut sowie gegen Pilze","volume":"10","author":"N\u00f6sner","year":"1994","journal-title":"Chirurgische Gastroenterologie"},{"key":"10.1016\/j.clnu.2012.11.014_bib22","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/AAC.44.6.1720-1724.2000","article-title":"Activities of taurolidine in\u00a0vitro and in experimental enterococcal endocarditis","volume":"44","author":"Torres-Viera","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clnu.2012.11.014_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.2042-7158.1990.tb07066.x","article-title":"In-vitro antibacterial activity of noxythiolin and taurolidine","volume":"42","author":"Blenkharn","year":"1990","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.clnu.2012.11.014_bib24","first-page":"1157","article-title":"In\u00a0vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms","volume":"42","author":"Zimmermann","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clnu.2012.11.014_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0261-5614(93)90034-2","article-title":"Taurolin for the prevention of parenteral nutrition related infection: antimicrobial activity and long-term use","volume":"12","author":"Johnston","year":"1993","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MPG.0b013e318162c428","article-title":"Taurolidine and catheter-related bloodstream infection: a systematic review of the literature","volume":"47","author":"Bradshaw","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2012.11.014_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhin.2010.05.020","article-title":"Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control?","volume":"76","author":"Meyer","year":"2010","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.clnu.2012.11.014_bib28","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/ndt\/gfl170","article-title":"Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces","volume":"21","author":"Shanks","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clnu.2012.11.014_bib29","article-title":"Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms","author":"Peters","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clnu.2012.11.014_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkg179","article-title":"Stability and in\u00a0vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis","volume":"51","author":"Droste","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.clnu.2012.11.014_bib31","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/AAC.46.6.1674-1679.2002","article-title":"Antimicrobial activity of a novel catheter lock solution","volume":"46","author":"Shah","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clnu.2012.11.014_bib32","article-title":"Long-term olive oil-based parenteral nutrition sustains innate immune function in home patients without active underlying disease","author":"Olthof","year":"2012","journal-title":"Clin Nutr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561412002622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561412002622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T07:53:16Z","timestamp":1540021996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561412002622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0261561412002622"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2012.11.014","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2012.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}